L-Citrulline

L-Citrulline

SCHEMBL20742804

NC(=O)NCCC[C@H](N)C(=O)O.[PbH2]

nearest known ligand 0.57

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
OTC P00480 1/20 0.57
DDAH1 O94760 4/20 0.53
GSR P00390 2/20 0.50
NOS2 P35228 4/20 0.48
CYP1A2 P05177 3/20 0.48
CYP2C19 P33261 2/20 0.48
TSHR P16473 2/20 0.48
GLA P06280 1/20 0.48
NFKB1 P19838 1/20 0.48
APEX1 P27695 1/20 0.48
KMT2A Q03164 2/20 0.47
ALOX15 P16050 1/20 0.47
BLM P54132 1/20 0.47
PMP22 Q01453 1/20 0.47
NOS1 P29475 4/20 0.46
NOS3 P29474 3/20 0.46
MEN1 O00255 1/20 0.46
ARG2 P78540 4/20 0.46
ARG1 P05089 3/20 0.46
CYP3A4 P08684 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
L-Citrulline SCHEMBL20742803 1.00 OTC (0.57) OTCDDAH1GSRNOS2CYP1A2
L-Citrulline SCHEMBL20587 0.98 OTC (0.59) OTCDDAH1GSRNOS2CYP1A2
L-Citrulline SCHEMBL15909604 0.98 OTC (0.59) OTCDDAH1GSRNOS2CYP1A2
L-Citrulline SCHEMBL15909605 0.98 OTC (0.59) OTCDDAH1GSRNOS2CYP1A2
L-Citrulline SCHEMBL9070200 0.98 OTC (0.59) OTCDDAH1GSRNOS2CYP1A2
L-Citrulline SCHEMBL4542892 0.98 OTC (0.59) OTCDDAH1GSRNOS2CYP1A2
L-Citrulline SCHEMBL22426116 0.98 OTC (0.59) OTCDDAH1GSRNOS2CYP1A2
L-Citrulline SCHEMBL437142 0.98 OTC (0.59) OTCDDAH1GSRNOS2CYP1A2
L-Citrulline SCHEMBL215403 0.98 OTC (0.59) OTCDDAH1GSRNOS2CYP1A2
L-Citrulline SCHEMBL288641 0.98 OTC (0.59) OTCDDAH1GSRNOS2CYP1A2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20190054312-A1 Method of Noninvasive Treatment of Diabetic Retinopathy QUON JUSTIN C (US) 2019-02-21 US disclosed